What is Blue Ridge Pathologists?
Established in 1994 and headquartered in Fishersville, Virginia, Blue Ridge Pathologists serves as a cornerstone of diagnostic excellence for Augusta Health and various private medical practices. The firm specializes in a comprehensive suite of anatomic and clinical pathology services, including complex cytopathology, surgical pathology, and hematopathology. With a team of board-certified experts boasting over six decades of collective experience, the company maintains a high-authority reputation for delivering precise, timely diagnostic data that is critical to patient outcomes. Their market position is defined by deep regional integration and a commitment to high-quality subspecialty diagnostics.
How much funding has Blue Ridge Pathologists raised?
Blue Ridge Pathologists has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Blue Ridge Pathologists
PPP
Public-Private Partnership
What's next for Blue Ridge Pathologists?
With the successful closure of this late-stage financing, Blue Ridge Pathologists is well-positioned to scale its diagnostic capabilities and potentially integrate advanced digital pathology technologies. The strategic roadmap likely involves enhancing laboratory throughput and expanding the reach of their subspecialty services to address the growing demand for precision medicine in western Virginia. As the firm transitions into this next phase of growth, the focus will remain on maintaining clinical rigor while optimizing the efficiency of their diagnostic workflows to support broader healthcare networks.
See full Blue Ridge Pathologists company page
